Overview

Safety Study of Single Administration Intravenous Treatment for Influenza

Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and pharmacology of single administrations of AVI-7100, a candidate treatment for influenza.
Phase:
Phase 1
Details
Lead Sponsor:
Sarepta Therapeutics
Sarepta Therapeutics, Inc.
Treatments:
Radavirsen